XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (PDF )

XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (PDF )

5 $

Format: Publisher PDF File : 900 Publication Year: 2024

Earn 5 points worth 5 $
Category:

By DrugPatentWatch XARELTO Drug Profile, 2024
This report focuses on XARELTO and covers the following critical aspects of this drug:

United States patents
Expired United States patents
FDA Paragraph IV patent challenges
District Court patent litigation
Patent Trial and Appeal Board (PTAB) patent cases
European supplementary protection certificates (SPCs)
Clinical trials
Drug prices
Annual sales revenues
Finished product suppliers
Raw active pharmaceutical ingredient (API) sources

FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free update
Product Details

ASIN ‏ : ‎ B0CS997FGD
Publisher ‏ : ‎ Independently published (January 12, 2024)
Language ‏ : ‎ English
Paperback ‏ : ‎ 584 pages
ISBN-13 ‏ : ‎ 979-8875923647

Reviews

There are no reviews yet.

Be the first to review “XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (PDF )”

Related Products